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Hydrophilic matrices are an effective option for oral controlled release but can face challenges 
in terms of bioavailability and efficacy when used in conjunction with poorly-soluble, weakly 
basic drugs.  Attenuated total reflectance Fourier transform infrared (ATR-FTIR) imaging 
provides dynamic information relating to the location and chemical nature of both the sustained 
release matrix and the active pharmaceutical ingredient (API) during hydration/dissolution. In 
this study we have identif ied a model system combining itraconazole (IT), a poorly-soluble, 
weakly basic API that has a pKa in the physiological range, and hydroxypropyl methylcellulose 
(HPMC) which is a commonly used oral tablet matrix. This system was investigated to 
determine swelling kinetics at different pH at a fixed ionic strength and to facilitate the study 
of the influence of hydrating media pH on drug particle movement (translocation). 
Using ATR-FTIR imaging we were able to show that gel layer formation and swelling were 
independent of pH but highly dependent on the ionic strength of the hydrating medium in 
placebo tablets. When the ionic strength was fixed, gel layer formation and radial swelling 
were both shown to be pH dependent when IT was incorporated into the matrix. This was 
verified using optical imaging. 
The chemical specificity of ATR-FTIR imaging permitted the observation of transformational 
changes of IT from free base to the ionised form in the tablet core during hydration. This 
phenomenon was shown to be greater at pH 1.5 than pH 7. 
ATR-FTIR imaging was able to follow drug particle translocation at both pH 1.5 and pH 7, 
however, the extent of migration away from the tablet core was shown to be greater at lower 
pH. The location of the translocated particles within the gel layer was different between the 
two studied pHs with particles being located close to the erosion front at pH 7 and within the 
diffusion front at pH 1.5. In both pH environments translocated IT particles were shown to be 
predominantly in the free base form. No evidence of fully solubilised IT was observed in the 
surrounding medium due to the inherent aqueous solubility of IT being below the instrument 
detection limits.  
This work highlighted the value of utilising a chemically specific spectroscopic tool to increase 
the understanding of the nature of factors affecting the release of a pH-dependent, poorly- 
soluble drug from a hydrophilic matrix at different pH and permitted greater insight into what 










Hydrophilic matrix tablets based on hydroxypropyl methylcellulose (hypromellose, HPMC) are 
a favourable choice for oral extended drug release dosage forms for a number of reasons 
including the knowledge base for the technology, regulatory status, low cost of rate control 
polymer, ease of manufacture and relative inertness [1]. In contact with water, HPMC rapidly 
undergoes hydration and swelling with the formation of a gel layer, a dynamic 'shell' around 
the tablet core. The extent of the hydrated polymer increases through ingress of fluid into the 
tablet over time and contributes to controlling the release of the drug by modulating the rate 
of water ingress [2]. Drug dissolution in, and diffusion through, the matrix as well as erosion of 
the hydrated polymer under shear at the interface between the gel layer and the bulk medium 
also are processes that contribute to drug release. Understanding the mechanisms controlling 
rate of drug release from an HPMC hydrophilic matrix tablet can be pursued by considering 
the movement of three fronts inside the evolving matrix tablet over time (Fig. 1a) : the boundary 
between yet-to-be hydrated polymer and hydrated polymer (swelling front); between hydrated 
polymer and bulk aqueous medium (erosion front); within the hydrated gel where undissolved 
drug is in equilibrium with dissolved drug (diffusion front)  [1] [3]. The presence of solid 
undissolved drug particles in the hydrated gel layer can impair the swelling of the polymer 
matrix by restricting the disentanglement of the polymer chains, which may be an important 
parameter in the case of poorly water-soluble compounds with marked pH-dependent 
solubility. There is also a correlation between poor drug solubility and erosion of the matrix [4]. 
For poorly-soluble drugs in hydrophilic matrices, the erosion mechanism of the hydrated 
polymer is important as it is this erosion that results in the liberation of undissolved drug [4]. 
 
Previous studies have incorporated non-diffusing insoluble markers to gain insight and 
quantify swelling within the gel layer of hydrophilic matrix tablets (HPMC). The movement of 
the f luorescent markers was tracked and observed using a confocal laser scanning 
microscope [5].  Interestingly, analysis of the tracks indicated a wave of expansion that started 
and was greatest at the exterior, moving towards the core. The findings also suggested that 
as deeper layers started to expand, swelling continued in the outer layers.  
HPMC is chemically stable over the physiological pH range [6] however, the swelling 
properties of HPMC are strongly influenced by the ionic strength of the medium [7] [8]. The 
ionic strength can vary considerably in the fluid within the gastrointestinal tract and depending 
on fasted and fed states, can range from 0-0.5 mol/L, impacting on drug release from a 
hydrophilic polymer matrix [7]. Many different approaches have been used to investigate the 
formation of the hydrated gel layer and the impact of ionic strength employing a range of 
techniques [9] [10]. Bajwa et al. used real-time confocal fluorescence imaging to investigate 
movement and migration of the early stages of HPMC gel layer formation using the fluorophore 
Congo red, which selectively binds with the cellulosic unit and hence acts as a marker for the 
hydrated HPMC [8]. The authors concluded that gel layer growth was suppressed with 
increasing salt concentration of the hydration medium. 
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Poorly-soluble ionisable drugs will exhibit different dissolution behaviour within the 
physiological pH range. Weakly basic compounds exhibit a marked increase in solubility at 
low pH while being practically insoluble at neutral pH [2] [11]. A significant number of new 
drugs in development fall into this category [12], although the phenomenon may be 
ameliorated to a degree by incorporating pH-modifiers with in the matrix to yield improved in 
vivo performance [13]. A further method to achieve an improved oral bioavailability is by the 
creation of a water-soluble salt form of the weakly basic drug [14].  
FTIR imaging enables multiple spectra to be collected simultaneously, allowing a chemical 
image of the material to be generated relatively quickly [15] [16] [17]. From this, information 
about the polymer, drug and water distribution can be gained simultaneously. The advantage 
of this approach is the ability to provide characterisation of the molecular species present and 
morphology of the polymer matrix [16]. FTIR images consist of spectral and spatial information 
and therefore require additional steps for converting the data into chemically and physically 
significant information. There are several methodologies for doing this, the simplest involves 
plotting the peak height or peak area of a band from a known component .  
ATR-FTIR imaging has previously been used to study the mechanism of drug release from 
HPMC matrices. [18] [19] [20]. Work by van der Weerd and Kazarian described an approach 
to studying drug release from a tablet by using a combination of chemical imaging via ATR-
FTIR imaging and dissolution. Niacinamide incorporated into a HPMC matrix was used a 
model system [21]. Using a partial least squares regression (PLS) calibration, quantitative 
analysis for the concentration of water, polymer and drug as a function of time was possible.  
Hifumi et al have used ATR-FTIR imaging to investigate the influence of different polymer 
matrices on drug release. They studied ibuprofen loaded HPMC films as a rapid release model 
and ibuprofen loaded polyvinylpyrrolidone (PVP) films for extended release. By controlling the 
local pH by incorporating a pH modifier and ionic strength around the HPMC via a 
hydrophobicity modifier, drug release behaviour could be controlled [22]. 
Ewing et al used ATR-FTIR imaging combined with a polydimethylsiloxane microfluidic device 
to monitor the behaviour and release of ibuprofen in situ under flowing conditions at pH 1 and 
7. It was reported that the low pH environment inhibited the release of the drug due to 
conversion from the molecularly dispersed ibuprofen to the crystalline form [23]. 
 
The aim of the current study was to use a poorly water-soluble, weakly basic and lipophilic 
model drug system to develop an insight how these types of drugs behave within the tablet 
matrix. We have selected itraconazole (IT) as the chosen model drug as although it is not  a  
candidate for oral extended delivery from a hydrophilic matrix system it met the stated criteria 
for a suitable model compound for this work in that it exhibits pH-dependent and poor solubility, 
close to 1 ng/mL at pH 7 and 4 g/mL at pH 1 [24], with a pKa of 3.7. This is well inside the 
physiological pH range and characteristic of the most challenging compounds which might be 
considered for delivery from hydrophilic matrix systems. It also is very amenable to the 
spectroscopic imaging approaches we have applied in this work. As a basis for future work, in 
this exploration of the behaviour of IT within the hydrating matrix, the methodology adopted 
permitted an opportunity to gain an insight into how such drugs behave both as environmental 
pH changes and in the absence of a pH modifier within the matrix.  
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This study has used ATR-FTIR imaging to monitor the hydration of the polymer and migration 
of the drug in the diffusion front over time and examined the influence of ionic strength on the 
formation of the HPMC gel layer. ATR-FTIR imaging allowed dissolution to be studied in real-
time, mapping both the location of the drug and its chemical characteristics (e.g. ionisation 
state) as it dissolved. The behaviour of salt forms of a drug within polymeric systems has been 
characterised previously. However, the combined assessment of poor solubility, very weakly 
basic drug and excipients and water in a formulation undergoing dynamic changes including 
ionisation, dissolution, hydration, swelling, particle dislocation with a view to  informing future 
product design has not been reported [23].  The application of this approach will permit a 
greater understanding of the factors controlling drug release and enable a more effective 





2. Materials and methods 
2.1 Materials 
Itraconazole (99% Acros Organics) and HPMC (grade Methocel® K100M CR Premium grade) 
powders were used as received. For the hydration studies two different hydrating media were 
used to investigate pH effects; 0.1 M HCl solution (pH 1.5) and 
tris(hydroxymethyl)aminomethane hydrochloride buffer solution (tris buffer, purchased from 
Sigma Aldrich, molecular biology grade pH 7.2). In order to explore the influence of ionic 
strength on the hydration of the HPMC two different ionic strength solutions were investigated. 
In order to minimise Hofmeister series-like effects, ionic strength was managed by using 
monovalent buffering agents [25]. The 0.1 M HCl was prepared by diluting concentrated HCl 
37% with deionised water having a resistivity of 18.2 MΩ. For the low ionic strength tris buffer, 
a 0.1 M solution was prepared by carrying a 10-fold dilution of the as-received solution. In 
order to obtain the high ionic strength solutions a 1 M concentration was used. For the 1 M tris 
solution, the as-received buffer was used. For the high ionic strength solution at low pH, 
sodium chloride (general purpose grade, Fischer Scientif ic) was added to the 0.1 N HCl 
solution to increase the ionic strength to 1 M.  
2.2 Preparation and Characterisation of Tablets 
HPMC tablets containing 20% w/w itraconazole were prepared by tumble blending (Stuart 
STR4 rotator drive) for 5 hours at approximately 30 rpm. Flat-faced matrix tablets (10 mm) 
containing 90 mg total powder were manufactured by direct compression on a Specac Atlas 
Manual press (Specac, Orpington, UK) using a compaction pressure of 625 MPa and a 5 
minute compaction time. The average IT content (n=6) was determined using Near Infrared 
(NIR) and shown to be 19.37% w/w with a uniform distribution across the tablet as determined 
by Raman microscopy (supporting information S_Fig.1 and S_Fig.2). The advantages of using 
Raman microscopy rather than ATR-FTIR imaging to determine content uniformity of an API 
include enhanced spatial resolution, the possibility of achieving spot sizes less than 2 m, the 
ability to map larger areas [26] (the mid-IR ATR method is limited to a fields of view ~640x640 
m2 in our system) and easier discrimination of an aromatic API in an HPMC matrix. 
2.3 In vitro release studies 
Dissolution studies were carried out using Agilent 708 on the 20% w/w IT formulation (n=6) in 
900 ml of 0.1N HCL and 0.1M tris buffer using the USP Type-II method.  A paddle speed of 
75 rpm and a temperature of 37±0.5 °C was used in all experiments [27]. A 5 ml aliquot was 
withdrawn at different time intervals and assayed for IT using ultraviolet–visible spectroscopy 
(Agilent Cary 60) by measuring the absorbance at 257 nm.  
2.4 Collection of ATR-FTIR images   
Mid-IR spectroscopic images were collected using a Varian 680-IR spectrometer (Agilent 
Technologies LDA UK Limited, Stockport, UK) coupled to a variable temperature Golden Gate 
single reflection ATR sampling accessory (Specac, Orpington, UK) held at 37oC. Images were 
collected at a spectral resolution of 8 cm-1 with 8 co-additions. It was observed that an S/N 
advantage can be obtained by using a large number of background scans whilst maintaining 
the speed advantage of having fewer sample scans. Therefore, blank ATR crystal images at 
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a resolution of 8 cm-1 and 256 co-additions were used as a background reference for image 
processing. 
2.5 Hydration Experiments using ATR- FTIR Imaging 
Hydration studies on the tablets were performed as follows and shown schematically in Fig 1. 
Each tablet was placed on the ATR crystal such that approximately one-third of the ATR 
crystal surface was covered. Pressure was then applied to the tablet using a sapphire anvil 
and a good optical contact between the sample and the ATR crystal was confirmed by 
checking the quality of the image of the dry tablet, this limited swelling in the axial direction. A 
polyester ring, of larger diameter than the tablet itself to permit unimpeded radial expansion, 
was sealed around the tablet and 5 ml of sonicated pH 7 tris buffer or 0.1 N (pH 1.5) HCl 
(37oC) was carefully added from one side of the crystal as hydrating medium.  
Hydration was studied over a 3 hour period at a temperature of 37ºC, images were collected 
every 2 min for the first 10 min, every 10 min over the following 70 min and every 20 min for 
the remainder of the experiment.  Chemical images for each component in the system were 
generated by plotting the peak area of the 1630, 1510 and 1041 cm-1 bands to show the 
distribution of  water, IT and HPMC respectively using ISys 5.0 chemical imaging software 
(Malvern Instruments, Malvern, UK).  
It should be noted that this experimental arrangement permits only observation of swelling and 
water ingress, particle translocation if it occurs and dissolution/diffusion of the drug in the 
hydrated matrix. It is not capable of monitoring erosion due to the low shear environment that 
exists within the cell. However, this is not considered to be a limitation in this context as it still 
allows assessment of  within-tablet dynamics due to hydration and swelling at pH values within 
the tablet where drug will be insoluble (high pH medium) or have some solubility (low pH 
medium). 
2.6 Optical Imaging to determine to radial and axial swelling 
Optical images of the axial and radial swelling were collected using two Canon 5D MK3 digital 
cameras equipped with 100mm macro lenses, arranged to capture axial and radial images of 
the tablets simultaneously. Images were obtained from the HPMC placebo and the 20% w/w 
IT loaded HPMC formulation in dissolution media at pH 1.5 and 7 (n=6). The tablets were 
placed onto a 3-prong sample holder located in a glass cell and 40 ml of either 0.1N HCL or 
0.1M tris buffer was added. Images were collected at 5 minute intervals for a period of 180 
minutes. Data analysis was conducted using image analysis software (ImageJ 1.52a) to 
determine to the area change in both the axial and radial dimensions. Dimensional changes 
of the drug loaded tablets immersed in media at the two different pHs were statistically 
compared using a two-way analysis of variance (ANOVA) to determine the statistical 








Fig. 1a: Schematic of different fronts of a hydrating hydrophilic tablet, looking down onto the 
upper tablet surface as if one could see through it, highlighting dry core, swelling, diffusion 
and erosion fronts, adapted from Timmins et al. reproduced with permission from Therapeutic 
Delivery as agreed by Newlands Press Ltd [1]. (b): Schematic of ATR-FTIR imaging set-up 
over the course of the hydration period using a Focal Plane Array (FPA) detector. 
3.0 Results and Discussion 
3.1 In vitro release studies 
Dissolution profiles obtained for the 20% w/w IT loaded tablets (S _Fig 3) showed a marked 
difference in release rate between the two pHs. At pH 1.5 sustained release of  IT was 
observed over the 24h experiment, although when the experiment was stopped at this point, 
only 24% of the contained IT had been released. In contrast, the same IT tablets in the pH 7 
medium showed release to be <1% at 24 hours. There was no evidence of burst release during 
these measurements at either pH for this API/polymer matrix.  However, the results showed 
clear evidence of an increase in both dissolution rate and percentage IT release (associated 
with increased solubility of IT) in the pH 1.5 medium, as anticipated and in full agreement with 
previous studies [28]. 
3.2 ATR-FTIR Imaging of reference materials 
Reference spectra for IT, HPMC, 0.1 N HCl and tris buffer were generated by calculating the 
mean of the spectra obtained from a single image obtained as described in 2.4.  
Spectral profiles were generated from the average of ATR-FTIR images obtained of the 
reference materials and were used to identify species specific bands from which it was 
possible to generate chemical images (Fig 2). The bands of interest were shown to be the 
(OH) ~1620 cm-1 for water (used as a marker for tris buffer and 0.1 N HCl, due to water being 
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the main component), (C-O) ~1041 cm-1 for HPMC and aromatic (C=C) ~1510 cm-1 for the 




Fig. 2: Average ATR-FTIR imaging spectra obtained from reference materials, highlighting 
 (OH), (C-O) and (C=C) in water, HPMC and IT respectively. Highlighted bands used for 
peak area integration for images to show distribution of water, IT and HPMC. 
 
3.3 ATR-FTIR Imaging of HPMC tablets 
Mid-IR images of matrix tablet composed simply of HPMC hydrating at pH 1.5 and 7 using low 
and high ionic strength media over the 3 hour hydration period were generated using the 
bands identif ied in section 3.2 and show the evolution of  the ingress of water into the tablet 
matrix and the growth of the gel layer.  (Fig. 3). High intensity regions are coloured red, while 
low intensity regions are blue. Increasing intensity is denoted by the numerical values on the 
accompanying colour scale bars. 
From the water distribution images (Fig. 3a) it is evident that water ingress occurs rapidly and 
full penetration throughout the tablet, visible within the field of view, occurs by around 19 
minutes irrespective of the pH or ionic strength environment. HPMC distribution images show 
the (non-hydrated) tablet core is located towards the lower half  of the images (Fig. 3b). The 
intensity of this dark red/yellow HPMC distribution in the high ionic strength medium at pH 1.5 
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and 7 (Fig. 3b (iii) and (iv)) is far greater throughout the duration of the experiment in 
comparison to the low ionic strength images (Fig. 3b(i) and (ii)).  
 
 
Fig. 3: Selected ATR-FTIR images were collected over the time course of hydration 
experiments for placebo tablets in low and high ionic strength solutions at pH 1.5 and pH 7 
showing (a) water and (b) HPMC distribution. Images were generated using methods 
described in section 2.5. The dotted lines in the first column of images denotes the boundary 
between the tablet and air/water. 
 
 
To gain an insight into the gel layer behaviour, the peak area ratio of the (C-O) in the HPMC 
and the (OH) for water was plotted. The gel layer was defined as the cyan zone corresponding 
to values between 2.2 and 3.8, on the colour scale shown in Fig. 4 and consisted of a 
combination of water and polymer at varying concentrations. Fig. 4a and b clearly highlight 
the rapid formation of the gel layer at pH 1.5 and pH 7 in a low ionic strength environment. 
The dark red colour corresponded to regions with high polymer content. Conversely, regions 
of hydrated HPMC with increasing water content are denoted by the yellow, green and cyan 
zones respectively.  
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The gel layer behaviour is the same between the different pH environments for the pure HPMC 
with the same ionic strength (Fig 4). For the low ionic strength media (Fig. 4a and 4b), at both 
pH, initial swelling is observed from the 1 minute time point. The dry core diminishes rapidly 
and the gel layer recedes towards the edge of the field of view within the time frame of the 
experiment.  
For the high ionic strength images at pH 1.5 and 7, swelling is observed from the outset the 
gel layer is much more stable over the duration of the experiment (Fig. 4c and d). Thus 
confirming the ionic strength of the media had a significant impact on the gel layer behaviour. 
This is consistent with previous studies looking at the impact of ionic strength and HPMC gel 
formation [6] [8] [10], where the gel layer behaviour is shown to be independent of pH but 
highly dependent on the ionic strength of the medium. At higher ionic strength, less effective 




Fig. 4: ATR-FTIR images of HPMC/water peak area ratio images over hydration period, 
showing HPMC gel layer evolution for (a) pH 1.5 and (b) pH 7 low ionic strength solutions. (c) 
pH 1.5 and (d) pH 7 high ionic strength solutions.  
 
3.4 FTIR imaging hydration experiments on pure 20% w/w IT loaded tablets  
To determine the influence of pH on IT-containing matrices, the ionic strength of the hydration 
medium was matched whilst the pH was modified. The strategy adopted was to use the low 
ionic strength medium as described in Section 3.3, thereby ensuring that any changes 
observed to the drug could be attributed to the pH environment alone.  
Fig. 5 shows the results of the ATR-FTIR imaging hydration experiments performed on 20% 
w/w IT-loaded tablets hydrated with a low ionic strength medium (0.1 mol/L) at pH 1.5 and 7. 
Fig. 5a, 5b and 5c show the water, HPMC distribution and gel layer evolution over the 
timeframe of the experiment. These results are similar to those observed with the IT-free 
HPMC tablets in a low ionic strength medium, shown in Figs. 3 and 4. However, interrogation 
of the gel layer images shown Fig. 5c over the hydration period appears to show visible 
differences between the swelling behaviour in the two pH environments. 
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The distribution and dispersion of the total IT over the hydration period (Fig. 5d) differs 
dramatically between the two pH environments. At pH 7, an environment where the drug is 
very insoluble, the matrix expands and swells, taking some drug particles with it but the drug 
predominantly remains in the core and is not readily able to dissolve or disperse into the 
hydrating matrix, reflecting the in vitro dissolution data. However, at pH 1.5, as the HPMC 
matrix expands and swells the IT shows enhanced mobility and moves with the apparent 
diffusion front, which has improved definition and has more inherent structure at this pH. At 
pH 7 the diffusion front and the swelling front are likely to be almost coincident. As indicated 
previously, the solubility of IT is very different in the two pH environments. We hypothesise 
that the additional structure within the diffusion front, evident at pH 1.5, is related to the pH-
dependent solubility of IT [24] [29]. This has the potential to impact on the mechanism drug 
release kinetics [30] [31].  
The FTIR imaging data confirms that the HPMC swelling is similar at each pH for the placebo 
but is measurably different when IT is incorporated into the tablet. This suggests the possibility 
of an additional mechanism affecting drug release kinetics beyond pH enabled drug solubility 
in the hydrated matrix.  To explore this further and to inform the findings observed from the 
ATR-FTIR imaging, a program of work to determine the swelling kinetics of IT loaded tablets 
was conducted using optical imaging (see section 3.7). 
Evidence of undissolved IT particle movement was observed in both pH environments. This 
phenomenon of drug particle translocation has previously been studied using optical methods 
[4]. Using ATR-FTIR imaging, as the HPMC matrix swells and expands, undissolved drug 
particles moving outward in the expanding hydrated gel layer can be followed without the need 
for other markers, such as dyes or glass beads [8], advantageously it is possible to also 
confirm the chemical form of the drug as the particle is moving. 
Expanding the diffusion front area of images at selected time point permits the exploration of 
the translocation of the IT particles in more detail (Fig 6). In these enlarged images, it is 
possible to identify and track individual particles, an example of a tracked particle is highlighted 
at both pH 1.5 (Fig 6a) and pH 7 (Fig 6b) images. At each time point, the change in the position 
of the interface between the IT rich area and the surrounding medium was calculated. This 
was then subtracted from the measured distance of particles relative to their original position 
giving a measure of the relative movement of the particle and interface at each time point.    
Five particles were tracked from the pH 1.5 and 7 datasets and their movement is plotted in 
Fig 6c. It should be noted that due to the limited field of view of the ATR-imaging experimental 
set up, distances >400m away from the interface could not be measured. Differences were 
observed in the distribution and the number of particles between the pH 1.5 and 7 datasets 
suggesting that particles at pH 1.5 are moving a greater distance relative to the interface in 
comparison to those particles present in the pH 7 environment within the same timeframe. A 
two-way ANOVA determined that there was a statistically significant difference in the distance 
travelled by the particles in the pH 1.5 and 7 environments after 58 minutes (p=<0.05, n=5). 
This is most likely attributable to the low solubility of IT at higher pH impacting on the water 
uptake and swelling capacity of the tablet in comparison to that at pH 1.5. For reference, the 





Fig. 5: ATR-FTIR peak area integration images over hydration period, showing: (a) distribution 
of water; (b) distribution of HPMC; (c) HPMC:water peak area ratio images, showing HPMC 
gel layer evolution for pH 1.5 and 7; (d) distribution of total IT. 
We propose that as IT has much greater solubility at pH 1.5 it therefore will dissolve out of the 
matrix, effectively leaving a more “porous” structure than that observed at pH 7. This more 
porous matrix clearly has different expansion properties upon hydration as evidenced by the 
different outward IT particle translocation. Differences in the expansion properties were not 
observed in the placebo. Ultimately, monitoring actual drug particle movement by ATR-FTIR 
imaging, for a compound that shows pH dependent solubility, reveals more information 
pertaining to the nuances of the mechanism of drug release when compared to methods 
lacking chemical specificity, such as optical microscopy, to track glass beads. 
 
3.5 Investigating the nature of IT particles within different pH environments 
Infrared spectra were extracted across the central line of the highlighted particles in the images 
obtained after 28 minutes at pH 1.5 and pH 7, to determine if changes in particle mobility were 
linked to changes in the IT chemistry (Fig. 6d and 6e). The infrared spectra from the 
translocated particles were shown to be IT rich, although evidence of water and HPMC was 
also observed at both pH. Interestingly, the particle at pH 7 shows a greater intensity of HPMC 
across the particle in comparison to that at pH 1.5 as the edge of the diffusion front will be in 
different places due to the pH effect on IT solubility. Consequently, particles monitored will be 
located within different evolving fronts (swelling and diffusion) [1] [3] [4] depending on the pH. 
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As the tablet hydrates, the polymer chains start to relax creating the swelling front [32], this 
and the diffusion fronts move out further as the tablet continues to hydrate, translocating any 
undissolved particles inside the diffusion front with them.  
 
 
Fig. 6: ATR-FTIR images tracking an IT particle at selected time points at (a) pH 1.5 and (b) 
pH 7 (interface indicated by dashed white line in last pane), (c) Plot showing movement of 5 
discrete particles at each pH over time (p=<0.05),  FTIR spectra from selected pixels across 
the IT particle, showing that the particles are IT rich at the 28 minute time-point for (d) pH 1.5 





3.6 Chacterisation of the different forms of IT 
FTIR is sensitive to molecular structure, therefore it is reasonable to assume that 
spectroscopic differences will be associated with the different forms of IT (ionised/ non-ionised 
form). For the images generated here, showing the distribution of IT in Fig.5d and Fig. 6a and 
b, the (C=C) ~1510 cm-1 was used as the spectroscopic marker for IT. However, this band is 
present in both the ionised and un-ionised forms therefore it only shows the distribution of total 
IT. In order to ascertain that IR was sensitive to the different forms of IT, ATR-FTIR spectra 
were collected from IT salts (mono and dihydrochloride) prepared following procedures 
outlined previously [24] [33]. Clear differences were observed between spectra obtained from 
the free base and IT salts, predominantly in the C-H stretching region. The free base form 
exhibits a strong band at 2821 cm-1 associated with CH symmetric stretching vibrations of the 
methyl group (Fig.7a) which disappears when the drug is ionised. Therefore the 2821 cm-1 
band was used to generate peak area distribution images to show changes in IT chemistry 
over the course of the hydration period (Fig.7b). A greater intensity of undissolved free base 
is observed in the tablet core (towards the bottom of the image) for the high pH medium over 
the duration of the experiment. In contrast for the low pH environment, the intensity of the free 
base reduces rapidly as it starts to partially ionise, as expected with IT being more soluble at 
low pH. From this we can surmise that the IT is predominantly in the free base form in the 
images at the early time points at both pH 1.5 and pH 7. However IT remains in the free base 
form for the duration of the experiment behind the swelling front, with a small number of 
undissolved particles extending towards the diffusion front at pH 7. 
Conversely, at pH1.5 IT is predominantly in the ionised form at later time points, as illustrated 
by the loss of the free base (Fig. 7b), extending through to the outer edge of the diffusion front 
most probably due to improved solubility. A more detailed interrogation of the changes in 
chemistry of IT during the dissolution process can be performed by comparison of the infrared 
data extracted from the lowest 6 rows of pixels in these images. Binning the spectra within the 
pixels of the lowest six rows from images at 0, 33 and 198 minutes at both pH, it was possible 
to generate average spectra with sufficient S/N to elucidate differences in the IT chemistry 
between systems (Fig. 7c). It was observed that over the course of the dissolution experiment 
performed at pH 1.5 there was a subtle reduction in the intensity of the 2821 cm-1 band and a 
shift to higher wavenumber of the 2925 cm-1 band over time, which was indicative of a partial 
transformation of IT from the free base to the monohydrochloride form, shown more clearly in 
Figure 7d. Whereas at pH 7, there is no reduction in the intensity of the 2821 cm-1 band 
indicating that at pH 7, the IT remains in the free base form, with an associated lower solubility. 
ATR-FTIR imaging studies provide a direct understanding how the low solubility pH-
dependent drug, with a pKa in the physiological range, changes during the dissolution process. 
Following matrix swelling and expansion whilst tracking undissolved drug particles, in the way 
previous workers have tracked glass beads [4] it was possible to directly observe the 
relationship between particle translocation, drug solubility, ionisation state and distribution 
across the hydrated matrix at different media pHs. These factors will be important to drug 




Fig. 7: (a) Average ATR-FTIR imaging spectra obtained from IT free base, IT 
monohydrochloride and IT dihydrochloride with dotted line indicating s(CH) at 2821 cm-1(b) 
ATR-FTIR peak area integrated images generated using band at 2821 cm-1. (c) average ATR-
FTIR imaging spectra highlighting (CH) at 0, 33 and 198 minute timepoints for 20%w/w IT 
loaded tablets at pH 1.5 and 7. (d) average ATR-FTIR imaging spectra obtained from IT free 





3.7 Physical swelling kinetics- radial and axial swelling results on 20%w/w IT loaded 
tablets 
To supplement the ATR-FTIR data a series of swelling experiments were performed on both 
IT loaded and placebo tablets at pH 1.5 and pH 7. Examples of the optical images obtained 
from the placebo and 20% w/w IT loaded tablets for the 0 and 180 minute timepoint at pH 1.5 
and 7 for the radial and axial measurements are shown in S_Fig. 4, S_Fig.5, S_Fig 7 and 
S_Fig.8. The results obtained from the swelling measurements confirmed that the swelling of 
placebo HPMC tablets was independent of  pH, however there were a distinct difference in 
swelling behaviour of the 20% w/w IT loaded tablets in the different pH environments (Fig. 8).  
A greater of degree of swelling was observed at pH 1.5 over the period of the hydration. 
Statistical analysis was carried out on the 30, 60, 90, 150 and 180 minute time point data using 
a two-way ANOVA to determine if there is a significant difference in both axial and/or radial 
swelling between tablets in the pH 1.5 and 7 environments. The results indicate that no 
statistically significant difference was observed at the 30-minute time-point, however a 
significant difference (p=<0.05) was observed for the subsequent time points analysed. 
Statistical analysis was also carried out on the placebo data at the same time points, however 
no significant difference was found for either the axial or radial dimensions between the pH 
environments (S _Fig. 6). These findings are in agreement with the FTIR-ATR imaging data 
presented earlier and support the hypothesis that the reduced swelling capacity of the IT 
loaded tablets at pH 7, leads to a reduction in the translocation of IT particles in the diffusion 
layer and consequently, along with the poor solubility of IT under these conditions,  results in 
a retardation of IT release from these tablets. 
 
(a)                                                                    (b) 
Fig. 8: Percentage swelling data obtained from 20% w/w IT loaded tablets from(a) axial (b) 
radial measurements   
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This work highlights the value of utilising ATR-FTIR imaging to elucidate factors affecting the 
release of a pH-dependent, poorly-soluble drug from a hydrophilic matrix. This approach 
permits an understanding of the within-matrix dynamics of the drug and shows that although 
evidence of particle translocation was observed in both pH 1.5 and 7 environments , drug 
mobility was very different between the two.  
 
Using ATR-FTIR imaging to follow matrix swelling and expansion and track undissolved drug 
particles in the way previous workers have tracked glass beads [4], it was possible to observe 
the changing chemical nature of the drug as a particle moved within the diffusion front. At pH 
7 the drug remained in the free base form, which is poorly-soluble and therefore largely stayed 
within the core and the swelling front. At pH 1.5 however, the IT was partially ionised, 
becoming more soluble and was able to migrate into the diffusion front and eventually out into 
the surrounding medium. The IT containing tablets exposed to the low pH medium show a 
higher swelling rate and greater overall percentage swelling in comparison to those exposed 
to the pH 7 environment. No significant differences in the swelling behaviour were observed 
for placebo tablets. 
  
Therefore, we conclude that differential drug solubility observed across the pH range is not 
the sole reason for different release rates within different pH environments. Additionally, the 
presence of non-dissolved drug negatively impacts upon matrix swelling resulting in 
translocated free base drug particles being in the swelling front at pH 7 and partially ionised 
drug particles in the diffusion front at pH 1.5. In combination, differences in solubility of the 
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